Literature DB >> 8927226

Mean power spectra from pharmaco-electrocorticographic studies: relative baseline correction and log transformation for a proper analysis of variance to assess drug effects.

P A Koopman1, P A Wouters, F N Krijzer.   

Abstract

The effects of drugs on electrocorticographic activity (ECoG) of the rat are studied in a routine screen. ECoG is recorded for 6-min periods before drug/vehicle administration and starting at 20 and 45 min thereafter. For each period, a mean power spectrum is calculated. Drugs are tested in 25 rats according to a 5 x 5 Latin square design and effects are assessed with analysis of variance. The validity of this assessment depends on assumptions on the chosen statistical model and the distribution of the data. In this study we consider the relative and absolute baseline corrected data. The assumptions appear to be better fulfilled if together with a relative baseline correction a logarithmic transformation is applied to the data.

Entities:  

Mesh:

Year:  1996        PMID: 8927226     DOI: 10.1159/000119258

Source DB:  PubMed          Journal:  Neuropsychobiology        ISSN: 0302-282X            Impact factor:   2.328


  3 in total

1.  Persistent aberrant cortical phase-amplitude coupling following seizure treatment in absence epilepsy models.

Authors:  Atul Maheshwari; Abraham Akbar; Mai Wang; Rachel L Marks; Katherine Yu; Suhyeorn Park; Brett L Foster; Jeffrey L Noebels
Journal:  J Physiol       Date:  2017-09-19       Impact factor: 5.182

2.  Shift in interictal relative gamma power as a novel biomarker for drug response in two mouse models of absence epilepsy.

Authors:  Atul Maheshwari; Rachel L Marks; Katherine M Yu; Jeffrey L Noebels
Journal:  Epilepsia       Date:  2015-12-10       Impact factor: 5.864

3.  Two Sides of the Same Coin: ERP and Wavelet Analyses of Visual Potentials Evoked and Induced by Task-Relevant Faces.

Authors:  Rob H J Van der Lubbe; Izabela Szumska; Małgorzata Fajkowska
Journal:  Adv Cogn Psychol       Date:  2016-12-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.